Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing NaN - NaN of 69
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in United States (Daratumumab, Cyclophosphamide, Bortezomib)

Completed
Has Results
  • Multiple Myeloma
  • Mobile, Alabama
  • +25 more
Oct 7, 2021

Multiple Myeloma Trial in Germany, United States (LBH589)

Terminated
Has Results
  • Multiple Myeloma
  • Scottsdale, Arizona
  • +28 more
Jun 22, 2021

Multiple Myeloma Trial in United States (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Daratumumab, Lenalidomide)

Completed
  • Multiple Myeloma
  • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
  • +4 more
  • Birmingham, Alabama
  • +30 more
Mar 31, 2021

Multiple Myeloma Trial in United States (Oprozomib, Lenalidomide, Dexamethasone)

Terminated
Has Results
  • Multiple Myeloma
  • Huntsville, Alabama
  • +13 more
Mar 2, 2021

Multiple Myeloma Trial in United States (Farydak)

Recruiting
  • Multiple Myeloma
  • Indianapolis, Indiana
  • +6 more
Mar 15, 2021

Multiple Myeloma, Non-Hodgkin's Lymphoma Trial in Indianapolis (Meloxicam, Filgrastim)

Completed
Has Results
  • Multiple Myeloma
  • Non-Hodgkin's Lymphoma
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Cancer Center
Feb 2, 2021

Connect® MM- The Multiple Myeloma Disease Registry

Active, not recruiting
  • Multiple Myeloma
    • Huntsville, Alabama
    • +252 more
    Jan 21, 2021

    Lymphoma, Non-Hodgkin, Hodgkin Disease, Multiple Myeloma Trial in United States (TXA127, Placebo)

    Terminated
    • Lymphoma, Non-Hodgkin
    • +2 more
    • Duarte, California
    • +9 more
    Dec 7, 2020

    Cancer, Hematologic Malignancies, Multiple Myeloma Trial in Worldwide (Denosumab, Zoledronic acid, Placebo to Denosumab)

    Completed
    Has Results
    • Cancer
    • +5 more
    • Tucson, Arizona
    • +308 more
    Mar 19, 2020

    Multiple Myeloma, Multiple Myeloma in Relapse, Refractory Multiple Myeloma Trial in United States (ACTR087, SEA-BCMA)

    Terminated
    • Multiple Myeloma
    • +2 more
    • ACTR087
    • SEA-BCMA
    • Phoenix, Arizona
    • +6 more
    Mar 27, 2020

    Cancer, Breast Cancer, NSCLC Trial in United States (ABBV-075, Venetoclax)

    Completed
    • Cancer
    • +7 more
    • Scottsdale, Arizona
    • +9 more
    Nov 27, 2019

    Multiple Myeloma Trial in Worldwide (Siltuximab, Bortezomib, Placebo)

    Completed
    Has Results
    • Multiple Myeloma
    • Siltuximab
    • +3 more
    • Greenbrae, California
    • +83 more
    Nov 7, 2019

    Multiple Myeloma Trial in Canada, United States (Pomalidomide)

    Approved for marketing
    • Multiple Myeloma
    • Duarte, California
    • +41 more
    Nov 7, 2019

    Acute Myeloid Leukemia, MDS, Lymphoma Trial in United States (azacitidine)

    Completed
    • Acute Myeloid Leukemia
    • +4 more
    • Greenbrae, California
    • +10 more
    Nov 6, 2019

    Multiple Myeloma Trial in Indianapolis (Lenalidomide plus Melphalan during autologous stem cell transplantation, Lenalidomide

    Completed
    Has Results
    • Multiple Myeloma
    • Lenalidomide plus Melphalan during autologous stem cell transplantation
    • Lenalidomide maintenance
    • Indianapolis, Indiana
      IU Simon Cancer Center
    Oct 3, 2019

    Multiple Myeloma Trial in Worldwide (Placebo, Dexamethasone, Bortezomib)

    Completed
    Has Results
    • Multiple Myeloma
    • Placebo
    • +3 more
    • Tucson, Arizona
    • +56 more
    Sep 25, 2019

    Multiple Myeloma Trial in United States (Elotuzumab, Lenalidomide, Dexamethasone)

    Completed
    Has Results
    • Multiple Myeloma
    • Tucson, Arizona
    • +28 more
    Jul 8, 2019

    Multiple Myeloma Trial in Worldwide (Carfilzomib, Bortezomib, Dexamethasone)

    Completed
    Has Results
    • Multiple Myeloma
    • Burbank, California
    • +240 more
    Apr 1, 2019

    Multiple Myeloma Trial in Worldwide (Daratumumab)

    Approved for marketing
    • Multiple Myeloma
    • Phoenix, Arizona
    • +78 more
    Jan 11, 2019

    Multiple Myeloma Trial in Indianapolis (Sirolimus, Tacrolimus, Lenalidomide)

    Terminated
    Has Results
    • Multiple Myeloma
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Cancer Center
    Dec 17, 2018

    Multiple Myeloma Trial in Worldwide (DARATUMUMAB, DURVALUMAB)

    Completed
    Has Results
    • Multiple Myeloma
    • Duarte, California
    • +24 more
    Sep 18, 2018

    Multiple Myeloma Trial in United States (Bendamustine, Doxorubicin, Bortezomib)

    Terminated
    • Multiple Myeloma
    • Indianapolis, Indiana
    • +5 more
    Jul 12, 2018

    Multiple Myeloma Trial in Worldwide (Elotuzumab, Bortezomib, Dexamethasone)

    Completed
    Has Results
    • Multiple Myeloma
    • Elotuzumab
    • +2 more
    • Corona, California
    • +76 more
    Apr 20, 2018

    Multiple Myeloma Trial in United States (Group A: Carfilzomib & Non-IMiD Regimen, Group B: Carfilzomib & IMiD containing

    Completed
    • Multiple Myeloma
    • Group A: Carfilzomib & Non-IMiD Regimen
    • Group B: Carfilzomib & IMiD containing regimen.
    • Encinitas, California
    • +8 more
    Mar 1, 2018

    Multiple Myeloma Trial in Canada, United States (CC-5013, Dexamethasone)

    Completed
    Has Results
    • Multiple Myeloma
    • Hoover, Alabama
    • +48 more
    Sep 18, 2017